| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; human; loading ...; fig s6b
| Oakes B, Fellmann C, Rishi H, Taylor K, Ren S, Nadler D, et al. CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification. Cell. 2019;176:254-267.e16 pubmed publisher |
- western blot; human; loading ...; fig 2c
| Charpentier M, Khedher A, Menoret S, Brion A, Lamribet K, Dardillac E, et al. CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair. Nat Commun. 2018;9:1133 pubmed publisher |
| Ilahibaks N, Kluiver T, de Jong O, de Jager S, Schiffelers R, Vader P, et al. Extracellular vesicle-mediated delivery of CRISPR/Cas9 ribonucleoprotein complex targeting proprotein convertase subtilisin-kexin type 9 (Pcsk9) in primary mouse hepatocytes. J Extracell Vesicles. 2024;13:e12389 pubmed publisher |
| Pettitt S, Shao N, Zatreanu D, Frankum J, Bajrami I, Brough R, et al. A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variant. Oncogene. 2023;42:2701-2709 pubmed publisher |
| Zelceski A, Francica P, Lingg L, Mutlu M, Stok C, Liptay M, et al. MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells. Cell Rep. 2023;42:112484 pubmed publisher |
| Tanaka M, Chuaychob S, Homme M, Yamazaki Y, Lyu R, Yamashita K, et al. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma. Nat Commun. 2023;14:1957 pubmed publisher |
| Szczerba M, Johnson B, Acciai F, Gogerty C, McCaughan M, Williams J, et al. Canonical cellular stress granules are required for arsenite-induced necroptosis mediated by Z-DNA-binding protein 1. Sci Signal. 2023;16:eabq0837 pubmed publisher |
| Zhang C, Schekman R. Syncytin-mediated open-ended membrane tubular connections facilitate the intercellular transfer of cargos including Cas9 protein. elife. 2023;12: pubmed publisher |
| Zhang Y, Rabinovsky R, Wei Z, El Fatimy R, Deforzh E, Luan B, et al. Secreted PGK1 and IGFBP2 contribute to the bystander effect of miR-10b gene editing in glioma. Mol Ther Nucleic Acids. 2023;31:265-275 pubmed publisher |
| Cappellesso F, Orban M, Shirgaonkar N, Berardi E, Serneels J, Neveu M, et al. Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer. Nat Cancer. 2022;3:1464-1483 pubmed publisher |
| Abrego J, Sanford Crane H, Oon C, Xiao X, Betts C, Sun D, et al. A Cancer Cell-Intrinsic GOT2-PPARδ Axis Suppresses Antitumor Immunity. Cancer Discov. 2022;12:2414-2433 pubmed publisher |
| Sakashita A, Ariura M, Namekawa S. CRISPR-Mediated Activation of Transposable Elements in Embryonic Stem Cells. Methods Mol Biol. 2022;2509:171-194 pubmed publisher |
| Unlu G, Prizer B, Erdal R, Yeh H, Bayraktar E, Birsoy K. Metabolic-scale gene activation screens identify SLCO2B1 as a heme transporter that enhances cellular iron availability. Mol Cell. 2022;: pubmed publisher |
| Park S, Uchida T, Tilson S, Hu Z, Ma C, Leek M, et al. A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells. Mol Ther Nucleic Acids. 2022;28:656-669 pubmed publisher |
| Economos N, Quijano E, Carufe K, Perera J, Glazer P. Antispacer peptide nucleic acids for sequence-specific CRISPR-Cas9 modulation. Nucleic Acids Res. 2022;50:e59 pubmed publisher |
| Bozoglu T, Lee S, Ziegler T, Jurisch V, Maas S, Baehr A, et al. Endothelial Retargeting of AAV9 In Vivo. Adv Sci (Weinh). 2022;9:e2103867 pubmed publisher |
| Uchida T, Park S, Inuzuka T, Zhang M, Allen J, Chayama K, et al. Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection. Mol Ther Methods Clin Dev. 2021;23:597-605 pubmed publisher |
| Bailey M, Tieu D, Habsid A, Tong A, Chan K, Moffat J, et al. Paralogous synthetic lethality underlies genetic dependencies of the cancer-mutated gene STAG2. Life Sci Alliance. 2021;4: pubmed publisher |
| Ah Fong A, Boyd A, Matson M, Judelson H. A Cas12a-based gene editing system for Phytophthora infestans reveals monoallelic expression of an elicitor. Mol Plant Pathol. 2021;22:737-752 pubmed publisher |
| Lamb A, Wang Z, Simmer P, Chung H, Wittkopp P. ebony affects pigmentation divergence and cuticular hydrocarbons in Drosophila americana and D. novamexicana. Front Ecol Evol. 2020;8: pubmed publisher |
| Zhao X, Jin C, Dong T, Sun Z, Zheng X, Feng B, et al. Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae. Hear Res. 2020;394:107999 pubmed publisher |
| Alix E, Godlee C, Cerny O, Blundell S, Tocci R, Matthews S, et al. The Tumour Suppressor TMEM127 Is a Nedd4-Family E3 Ligase Adaptor Required by Salmonella SteD to Ubiquitinate and Degrade MHC Class II Molecules. Cell Host Microbe. 2020;28:54-68.e7 pubmed publisher |
| Liu Y, Chen J, Crisante D, Jaramillo Lopez J, Mahadevan R. Dynamic Cell Programming with Quorum Sensing-Controlled CRISPRi Circuit. ACS Synth Biol. 2020;9:1284-1291 pubmed publisher |
| Yu Y, Leete T, Born D, Young L, Barrera L, Lee S, et al. Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity. Nat Commun. 2020;11:2052 pubmed publisher |
| Kang W, Zhao X, Sun Z, Dong T, Jin C, Tong L, et al. Adeno-associated virus vector enables safe and efficient Cas9 activation in neonatal and adult Cas9 knockin murine cochleae. Gene Ther. 2020;: pubmed publisher |
| Wu Y, Yang L, Chang T, Kandeel F, Yee J. A Small Molecule-Controlled Cas9 Repressible System. Mol Ther Nucleic Acids. 2020;19:922-932 pubmed publisher |
| Wilk A, Hayat F, Cunningham R, Li J, Garavaglia S, Zamani L, et al. Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity. Sci Rep. 2020;10:651 pubmed publisher |
| Li X. Gap junction protein connexin43 and tunneling nanotubes in human trabecular meshwork cells. Int J Physiol Pathophysiol Pharmacol. 2019;11:212-219 pubmed |
| Schick S, Rendeiro A, Runggatscher K, Ringler A, Boidol B, Hinkel M, et al. Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers. Nat Genet. 2019;51:1399-1410 pubmed publisher |
| Johnston R, Seamon K, Saada E, Podlevsky J, Branda S, Timlin J, et al. Use of anti-CRISPR protein AcrIIA4 as a capture ligand for CRISPR/Cas9 detection. Biosens Bioelectron. 2019;141:111361 pubmed publisher |
| Savage A, Kurusamy S, Chen Y, Jiang Z, Chhabria K, MacDonald R, et al. tmem33 is essential for VEGF-mediated endothelial calcium oscillations and angiogenesis. Nat Commun. 2019;10:732 pubmed publisher |
| Qiang J, Ma Z, Xie X, Shi L, Geng Y, Hu J, et al. Multi-omic Analyses Reveal Minimal Impact of the CRISPR-Cas9 Nuclease on Cultured Human Cells. J Proteome Res. 2019;18:1054-1063 pubmed publisher |
| Melnik S, Dvornikov D, Muller Decker K, Depner S, Stannek P, Meister M, et al. Cancer cell specific inhibition of Wnt/?-catenin signaling by forced intracellular acidification. Cell Discov. 2018;4:37 pubmed publisher |
| Sykora P, Witt K, Revanna P, Smith Roe S, Dismukes J, Lloyd D, et al. Next generation high throughput DNA damage detection platform for genotoxic compound screening. Sci Rep. 2018;8:2771 pubmed publisher |
| Basila M, Kelley M, Smith A. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity. PLoS ONE. 2017;12:e0188593 pubmed publisher |
| Rogers Z, McFarland C, Winters I, Naranjo S, Chuang C, Petrov D, et al. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nat Methods. 2017;14:737-742 pubmed publisher |
| El Fatimy R, Subramanian S, Uhlmann E, Krichevsky A. Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b. Mol Ther. 2017;25:368-378 pubmed publisher |
| Chew W, Tabebordbar M, Cheng J, Mali P, Wu E, Ng A, et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat Methods. 2016;13:868-74 pubmed publisher |
| Choi J, Dang Y, Abraham S, Ma H, Zhang J, Guo H, et al. Lentivirus pre-packed with Cas9 protein for safer gene editing. Gene Ther. 2016;23:627-33 pubmed publisher |
| Chu V, Weber T, Graf R, Sommermann T, Petsch K, Sack U, et al. Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes. BMC Biotechnol. 2016;16:4 pubmed publisher |
| Chiou S, Winters I, Wang J, Naranjo S, Dudgeon C, Tamburini F, et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes Dev. 2015;29:1576-85 pubmed publisher |
